Feasibility outcomes
’, bleeding, itching, pain
ADVERSE EVENTS, BLEEDING
The feasibility outcomes of this study included [Consent rate: consent rate was the primary outcome. We chose consent rate as the primary outcome as we wanted to know whether women would be interested in participating in a PFMT program as per the guidelines recommended by the National Institute for Health and Care Research which advises that willingness to participate in an intervention should be established [Retention rate: retention rate was calculated at the end of the intervention period using the number of participants who complete the 12-week trial divided by the number of participants who initially consented to the trial.Attendance rate: attendance rate was calculated at the end of the intervention period using the number telehealth of sessions attended out of eight.Adherence rate: the adherence to home exercise program was calculated at the end of the intervention period using the number of days the participant completed the home exercise program divided by 83 days (12 weeks).Withdrawal rate: the withdrawal rate was calculated at the end of the intervention period using the number of participants who withdrew from the trial after consenting divided by the number of participants who initially consented to the trial.Adverse and serious adverse events: the number of adverse or serious adverse events was assessed during telehealth consultations throughout the 12-week intervention period. Participants were asked about any pelvic symptoms (such as pain, intravaginal bleeding or itching) at each session. They were also encouraged to contact the research team as soon as they experienced any of these symptoms.Acceptability: the acceptability of the intervention was assessed using purpose-designed questions related to the participant experience of PFMT exercise program and use of femfitSatisfaction: the satisfaction of the intervention was assessed using a five-point Likert-scale ranging from ‘1 = very dissatisfied’ to ‘5 = very satisfied’.